Welcome to LookChem.com Sign In|Join Free

CAS

  • or

306761-16-0

Post Buying Request

306761-16-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

306761-16-0 Usage

Description

Methyl 2-methyl-2-(3,4-difluorophenyl)propionate is a colorless liquid ester with a fruity odor, commonly used as a flavoring agent in the food and beverage industry, as well as in perfumes and fragrances due to its pleasant aroma. It also has potential applications in the pharmaceutical industry as a precursor for the synthesis of various drugs and pharmaceutical compounds.

Uses

Used in Food and Beverage Industry:
Methyl 2-methyl-2-(3,4-difluorophenyl)propionate is used as a flavoring agent to add a sweet and fruity taste to various products.
Used in Perfume and Fragrance Industry:
Methyl 2-methyl-2-(3,4-difluorophenyl)propionate is used as a fragrance ingredient to provide a pleasant aroma to perfumes and other scented products.
Used in Pharmaceutical Industry:
Methyl 2-methyl-2-(3,4-difluorophenyl)propionate is used as a precursor in the synthesis of various drugs and pharmaceutical compounds.
It is important to handle this chemical with care as it can be harmful if ingested, inhaled, or comes into contact with the skin or eyes.

Check Digit Verification of cas no

The CAS Registry Mumber 306761-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,7,6 and 1 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 306761-16:
(8*3)+(7*0)+(6*6)+(5*7)+(4*6)+(3*1)+(2*1)+(1*6)=130
130 % 10 = 0
So 306761-16-0 is a valid CAS Registry Number.

306761-16-0Downstream Products

306761-16-0Relevant articles and documents

Heterosubstituted pyridine derivatives as PDE4 inhibitors

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3′,5′-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). or a pharmaceutically acceptable salt or hydrate thereof. The invention also encompasses pharmaceutical compositions and methods for treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 306761-16-0